Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis

Strahlentherapie und Onkologie

Volumn 187, Issue 9, 2011, Pages 541-547

  Rades, Dirk ^a   Meyners, Thekla ^a   Kazic, Nadja ^b   Bajrovic, Amira ^c   Rudat, Volker ^d   Schild, Steven E ^e  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^c UNIVERSITY OF HAMBURG   (Germany)

^d SAAD SPECIALIST HOSPITAL   (Saudi Arabia)

^e MAYO CLINIC   (United States)

Author keywords

Head and neck cancer; Radiochemotherapy; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL; HEMOGLOBIN;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED STUDY; DEATH; DISEASE FREE SURVIVAL; FEMALE; FIBROSIS; GENDER; HEAD AND NECK CARCINOMA; HEMATOLOGIC DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; NAUSEA; OVERALL SURVIVAL; PROGNOSIS; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VOMITING; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HEMOGLOBINOMETRY; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 80755163551     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2262-2     Document Type: Article

References (20)

1. Becker A, Stadler P, Lavay RS et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2000;46:459-66. (Pubitemid 30067797)
2. Bruner DW, Wasserman T. The impact on quality of life by radiation late effects. Int J Radiat Oncol Biol Phys 1995;31:1353-5.
3. Budach V, Stuschke M, Budach W et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than doseescalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 2005;23:1125-35. (Pubitemid 46202268)
4. Calais G, Pointreau Y, Alfonsi M et al. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2001-01. J Clin Oncol 2006;24(Suppl):281S.
5. Cerezo L, Millan I, Torre A et al. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer 1992;69:1224-34.
6. Denis F, Garaud P, Bardet E et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004;22:69-76. (Pubitemid 41095116)
7. Jeremic B, Milicic B. Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol 2009;32:163-8.
8. Jeremic B, Milicic B, Dagovic A et al. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2004;22:3540-8. (Pubitemid 41103660)
9. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
10. Leemans CR, Tiwari R, Nauta JJ et al. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993;71:452-6. (Pubitemid 23021234)
11. Leibel SA, Scott CB, Mohiuddin M et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991;21:549-56.
12. Platteaux N, Dirix P, Hermans R et al. Brachial plexopathy after chemoradiotherapy for head and neck squamous cell carcinoma. Strahlenther Onkol 2010;186:517-20.
13. Posner, MR, Norris CM, Wirth LJ et al. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 2009;20:921-7.
14. Rudat V, Stadler P, Becker A et al. Predictive value of the tumor oxygenation by means of pO2 histography in patients with advanced head and neck cancer. Strahlenther Onkol 2001;177:462-8. (Pubitemid 32861426)
15. Soo KC, Tan EH, Wee J et al. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 2005;93:279-86. (Pubitemid 43080029)
16. Steinmann D, Cerny B, Karstens JH et al. Chemoradiotherapy with weekly cisplatin 40 mg/m (2) in 103 head-and-neck cancer patients: a cumulative doseeffect analysis. Strahlenther Onkol 2009;185:682-8.
17. Tribius S, Kronemann S, Kilic Y et al. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:675-81.
18. Wendt TG, Grabenbauer GG, Rodel CM et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998;16:1318-24. (Pubitemid 28175746)
19. Wolff HA, Bosch J, Jung K et al. High-grade acute organ toxicity as positive prognostic factor in primary radio (chemo) therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 2010;186:262-8.
20. Zwicker F, Hauswald H, Nill S et al. New multileaf collimator with a leaf width of 5 mm improves plan quality compared to 10 mm in step-and-shoot IMRT of HNC using integrated boost procedure. Strahlenther Onkol 2010;186:334-43.